Related Experiment Videos

Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination

T V Murphy1, K E White, P Pastor

  • 1Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas 75235-9063.

JAMA
|January 13, 1993
PubMed

Insights

Vaccination significantly reduced invasive Haemophilus influenzae type b disease in children. The conjugate vaccine, introduced in 1988, showed substantial incidence declines, even in unvaccinated infants.

Area of Science:

  • Pediatric Infectious Diseases
  • Vaccinology
  • Epidemiology

Background:

  • Haemophilus influenzae type b (Hib) disease historically posed a significant threat to young children.
  • The introduction of polysaccharide and conjugate vaccines aimed to reduce the burden of Hib infections.

Purpose of the Study:

  • To assess the incidence of invasive Hib disease in Minnesota and Dallas County before and after vaccine introduction.
  • To evaluate the impact of plain polysaccharide and conjugate vaccines on Hib disease rates in children.

Main Methods:

  • Active, laboratory-based surveillance identified culture-proven cases of invasive Hib disease.
  • Incidence was calculated per 100,000 child-years, comparing baseline (1983-1984) to post-vaccination periods (through 1991).
  • Study included children under 5 years old in Minnesota and Dallas County, Texas.

Main Results:

  • Invasive Hib disease incidence decreased by 85% in Minnesota and 92% in Dallas County between the baseline and 1991.
  • Significant declines were observed in both vaccinated age groups and unvaccinated infants younger than 18 months.
  • A total of 2557 confirmed cases were analyzed from 1983 to 1991.

Conclusions:

  • Vaccination strategies have led to a profound reduction in invasive Hib disease in the studied US regions.
  • The findings suggest that Hib vaccines not only protect vaccinated individuals but also reduce disease transmission to unvaccinated populations.
  • The data support the effectiveness of conjugate vaccines in controlling Hib infections.
Abstract

Related Concept Videos